CureZone   Log On   Join
Three PubMed items on LD Naltrexone and Alpha Lipoic Acid for cancer
 
Dquixote1217 Views: 1,531
Published: 12 y
 

Three PubMed items on LD Naltrexone and Alpha Lipoic Acid for cancer


 By the highly credentialed Dr. Burton Berkson:

Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases.

Berkson BM, Rubin DM, Berkson AJ.

Integr Cancer Ther. 2009 Dec;8(4):416-22. doi: 10.1177/1534735409352082. Erratum in: Integr Cancer Ther. 2010 Jun;9(2):247.

PMID:
 
20042414
 
[PubMed - indexed for MEDLINE]
2.

Reversal of signs and symptoms of a B-cell lymphoma in a patient using only low-dose naltrexone.

Berkson BM, Rubin DM, Berkson AJ.

Integr Cancer Ther. 2007 Sep;6(3):293-6. No abstract available.

PMID:
 
17761642
 
[PubMed - indexed for MEDLINE]
3.

The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol.

Berkson BM, Rubin DM, Berkson AJ.

Integr Cancer Ther. 2006 Mar;5(1):83-9.

PMID:
 
16484716
 
[PubMed - indexed for MEDLINE]

 

Share


 
Printer-friendly version of this page Email this message to a friend
Alert Moderators
Report Spam or bad message  Alert Moderators on This GOOD Message

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


 

Donate to CureZone


CureZone Newsletter is distributed in partnership with https://www.netatlantic.com


Contact Us - Advertise - Stats

Copyright 1999 - 2025  www.curezone.org

0.219 sec, (6)